HEPA

Hepion Pharmaceuticals (HEPA)

About Hepion Pharmaceuticals (HEPA)

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.

Details

Daily high

$0.22

Daily low

$0.19

Price at open

$0.21

52 Week High

$3.49

52 Week Low

$0.12

Market cap

1.3M

Dividend yield

0.00%

Volume

37.3M

Avg. volume

36.6M

P/E ratio

-.04

Hepion Pharmaceuticals News